Breast biopsy systems is used to remove the tissues or fluids from suspicious areas. The removed cells are later examined, whether the suspicious area is cancerous or not can be diagnosed in the procedure. There are X-ray-guided biopsy systems, as well as ultrasound-guided, MRI-guided and stereotactic-guided ones.

Market Analysis and Insights: Global Breast Biopsy System Market
The global Breast Biopsy System market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Breast Biopsy System Scope and Market Size
The global Breast Biopsy System market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Breast Biopsy System market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
X-Ray-Guided
Ultrasound-Guided Biopsy System
MRI-Guided
Stereotactic-Guided
Others

Segment by Application
Hospital
Clinic

The Breast Biopsy System market is analysed and market size information is provided by regions (countries). Segment by Application, the Breast Biopsy System market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Aurora Healthcare
BD (Bard)
Hologic
Leica Biosystems (Mammotome)
Metaltronica
Planmeca Group (Planmed)
Siemens
Sterylab
Trivitron Healthcare